IBDEI0KK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9071,0)
 ;;=N06.9^^69^617^41
 ;;^UTILITY(U,$J,358.3,9071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9071,1,3,0)
 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
 ;;^UTILITY(U,$J,358.3,9071,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,9071,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,9072,0)
 ;;=N07.0^^69^617^29
 ;;^UTILITY(U,$J,358.3,9072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9072,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,9072,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,9072,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,9073,0)
 ;;=N07.1^^69^617^28
 ;;^UTILITY(U,$J,358.3,9073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9073,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,9073,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,9073,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,9074,0)
 ;;=N07.2^^69^617^24
 ;;^UTILITY(U,$J,358.3,9074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9074,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,9074,1,4,0)
 ;;=4^N07.2
 ;;^UTILITY(U,$J,358.3,9074,2)
 ;;=^5015561
 ;;^UTILITY(U,$J,358.3,9075,0)
 ;;=N07.3^^69^617^25
 ;;^UTILITY(U,$J,358.3,9075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9075,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,9075,1,4,0)
 ;;=4^N07.3
 ;;^UTILITY(U,$J,358.3,9075,2)
 ;;=^5015562
 ;;^UTILITY(U,$J,358.3,9076,0)
 ;;=N07.4^^69^617^23
 ;;^UTILITY(U,$J,358.3,9076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9076,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,9076,1,4,0)
 ;;=4^N07.4
 ;;^UTILITY(U,$J,358.3,9076,2)
 ;;=^5015563
 ;;^UTILITY(U,$J,358.3,9077,0)
 ;;=N07.5^^69^617^26
 ;;^UTILITY(U,$J,358.3,9077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9077,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,9077,1,4,0)
 ;;=4^N07.5
 ;;^UTILITY(U,$J,358.3,9077,2)
 ;;=^5015564
 ;;^UTILITY(U,$J,358.3,9078,0)
 ;;=N07.6^^69^617^22
 ;;^UTILITY(U,$J,358.3,9078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9078,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,9078,1,4,0)
 ;;=4^N07.6
 ;;^UTILITY(U,$J,358.3,9078,2)
 ;;=^5015565
 ;;^UTILITY(U,$J,358.3,9079,0)
 ;;=N07.7^^69^617^27
 ;;^UTILITY(U,$J,358.3,9079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9079,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,9079,1,4,0)
 ;;=4^N07.7
 ;;^UTILITY(U,$J,358.3,9079,2)
 ;;=^5015566
 ;;^UTILITY(U,$J,358.3,9080,0)
 ;;=N07.8^^69^617^30
 ;;^UTILITY(U,$J,358.3,9080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9080,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ oth morphologic lesions
 ;;^UTILITY(U,$J,358.3,9080,1,4,0)
 ;;=4^N07.8
 ;;^UTILITY(U,$J,358.3,9080,2)
 ;;=^5015567
 ;;^UTILITY(U,$J,358.3,9081,0)
 ;;=N07.9^^69^617^31
 ;;^UTILITY(U,$J,358.3,9081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9081,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ unsp morphologic lesions
 ;;^UTILITY(U,$J,358.3,9081,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,9081,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,9082,0)
 ;;=N08.^^69^617^21
 ;;^UTILITY(U,$J,358.3,9082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9082,1,3,0)
 ;;=3^Glomerular disorders in diseases classified elsewhere
